Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalizing Post Surgical Thromboprophylaxis for Patients With Peripheral Artery Disease

NCT07613840 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07613840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07613840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalizing Post Surgical Thromboprophylaxis for Patients With Peripheral Artery Disease
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 29, 2025
Completion date
June 30, 2027
Enrollment
484 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amputation, peripheral arterial disease (pad), platelet aggregation inhibitors, pru(platelet reactivity unit), thromboelastography (teg), thrombosis, thrombosis (stent thrombosis)